Currently Available Therapeutic Options for MM MM is currently one of the most prevalent haematological malignancies, which mainly affects individuals aged above 65 2 , a relatively vulnerable group of patients owing to comorbidities and immunosenes...
The Multitude of Activities of IMiDs Because of the established benefits, IMiDs are recommended as induction therapy for both transplant eligible and ineligible patients, in the post-transplant maintenance setting, and for relapsed/refractory diseas...
Background Information The patient of the current case was a 64-year-old male with documented ischemic heart disease and received 3 times of percutaneous coronary intervention (PCI), respectively in 2004, 2005 and 2013. In 2015, the patient complain...
Where Are We in the Prevention of CRC? Ageing and male gender are common risk factors for CRC. In addition, a positive family history, a history of familial adenomatous polyposis, occurrence of Lynch syndrome, development of colonic polyp, and ulcer...
Exploring Chemotherapy-associated Cognitive Impairment in Colorectal Cancer Chemotherapy, which is commonplace in treating a plethora of cancers, has seen increasing concerns over its possible role in inducing cognitive impairment 1 . In breast canc...
Reduced Overall Survival in Refractory MM Although the application of the first IMiD, lenalidomide, had significantly increased median overall survival (OS) 2 , Prof. Leleu commented that the treatment success was hindered by the refractoriness of M...
Background of the Patient The patient was a 53-year-old female with good health record. In 2010, the patient presented with some bone pain and proteinuria (2.5 g/day). However, evaluation on albumin level did not indicate renal impairment. Dr. Hwang...
Therapeutic Sequencing Strategy in Multiple Myeloma Date: 24 th June 2021 (Thursday) Time: 19:00 - 20:40 (GMT+8, HKT) Meeting format: Zoom meeting Address: Salon Room III, Hyatt Regency Hong Kong, 18 Hanoi Road, Tsim Sha Tsui, Kowloon The survival o...
Breast cancer ranks the first place among female cancers in Hong Kong, with the incidence increased nearly 4 times within the past 25 years. Although a wide spectrum of therapies for breast cancer is currently available, the prognosis of the disease...
The Potential and Challenge of Gene-edited Cellular Therapies The recent advances in genome editing allow precise manipulation of cellular DNA sequences and have raised hopes of curing serious genetic diseases. CRISPR-Cas9 is a specific and efficien...
Nutrition Intervention for Improving Health Outcomes of Cancer Patients Malnutrition is prevalent among cancer patients, whereas up to 70% of patients are at risk. The condition can adversely affect treatment outcomes, quality of life and survival 1...
Over the past 25 years, significant progress has been made in the treatment of multiple myeloma (MM) as reflected by the improved overall survival (OS). However, in relapsed and refractory MM (RRMM), median OS decreases with each extra line of thera...
